Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial

Background: To investigate whole-body contrast-enhanced CT and hepatobiliary contrast liver MRI for the detection of extrahepatic disease (EHD) in hepatocellular carcinoma (HCC) and to quantify the impact of EHD on therapy decision. Methods: In this post-hoc analysis of the prospective phase II open...

Descripción completa

Detalles Bibliográficos
Autores principales: Geyer, Thomas, Kazmierczak, Philipp M., Steffen, Ingo G., Malfertheiner, Peter, Peynircioglu, Bora, Loewe, Christian, van Delden, Otto, Vandecaveye, Vincent, Gebauer, Bernhard, Pech, Maciej, Sengel, Christian, Bargellini, Irene, Iezzi, Roberto, Benito, Alberto, Zech, Christoph J., Gasbarrini, Antonio, Schütte, Kerstin, Ricke, Jens, Seidensticker, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139039/
https://www.ncbi.nlm.nih.gov/pubmed/35625900
http://dx.doi.org/10.3390/biomedicines10051156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139039/
https://www.ncbi.nlm.nih.gov/pubmed/35625900
http://dx.doi.org/10.3390/biomedicines10051156

Ejemplares similares